The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner.
about
The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The TAT-RasGAP317-326 anti-can ...... ecroptosis-independent manner.
@en
The TAT-RasGAP317-326 anti-can ...... ecroptosis-independent manner.
@nl
type
label
The TAT-RasGAP317-326 anti-can ...... ecroptosis-independent manner.
@en
The TAT-RasGAP317-326 anti-can ...... ecroptosis-independent manner.
@nl
prefLabel
The TAT-RasGAP317-326 anti-can ...... ecroptosis-independent manner.
@en
The TAT-RasGAP317-326 anti-can ...... ecroptosis-independent manner.
@nl
P2093
P2860
P356
P1433
P1476
The TAT-RasGAP317-326 anti-can ...... ecroptosis-independent manner.
@en
P2093
Aimable Nahimana
Christiane Margue
Dagmar Kulms
David Barras
Mathieu Heulot
Nadja Chevalier
Stephanie Kreis
Sébastien Michel
P2860
P304
64342-64359
P356
10.18632/ONCOTARGET.11841
P407
P577
2016-09-02T00:00:00Z